News from the Institute of Cancer Sciences
News from the Institute of Cancer Sciences
@GUcancersci on Twitter
Tue, 14 May 2019 14:54:00 BST
Scottish science is set to receive a multimillion pound boost to transform training for doctors who undertake cancer research. Cancer Research UK is to award over £6 million to its research centres in Glasgow and Edinburgh to train early-career clinician scientists.
Wed, 19 Dec 2018 14:40:00 GMT
Scientists at the University of Glasgow have discovered a potential combination therapy for the treatment of chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in the Western world, diagnosed in more than 3,500 people in the UK each year.
Fri, 17 Aug 2018 14:13:00 BST
Wed, 07 Mar 2018 15:16:00 GMT
Mhairi Copland, Professor of Translational Haematology and Honorary Consultant Haematologist has recently taken over as Director of the Paul O'Gorman Leukaemia Research Centre and Head of Experimental Haematology Section
Fri, 16 Feb 2018 15:25:00 GMT
University of Glasgow scientists are set to receive a major grant for pioneering research into cancer. Cancer Research UK is planning to invest nearly £4.5 million over the next five years in ground-breaking work at the Cancer Research UK Clinical Trials Unit (CTU) in Glasgow. The grant will allow doctors and scientists to continue researching and testing better and kinder treatments for patients.
Mon, 08 May 2017 08:00:00 BST
The Institute of Cancer Sciences (ICS) and the Institute of Molecular, Cell and Systems Biology (IMCSB) have become the latest University of Glasgow recipients of a prestigious Athena SWAN Bronze award today, 8 May 2017.
Tue, 09 May 2017 15:17:00 BST
Finding a cure for chronic myeloid leukaemia (CML) could be accelerated by a new virtual platform that allows researchers easy access to data from patient samples generated by laboratories around the world. LEUKomics, which has been launched by scientists at the University of Glasgow and the University of Melbourne, is a comprehensive database describing over 100 CML samples. It is completely free for researchers to use and share.
The new Miss Scotland, Lucy Kerr, has chosen Action Medical Research as her charity to fundraise for this year.
Tue, 06 Dec 2016 16:08:00 GMT
The new Miss Scotland, Lucy Kerr, has chosen Action Medical Research as her charity to fundraise for this year. Lucy has identified our project - 177Lu-DOTATATE combined with radiosensitisers to enhance targeted radiotherapy of neuroblastoma - of particular interest to her.
Thu, 17 Nov 2016 10:35:00 GMT
The BACR/AstraZeneca/Young Scientist Frank Rose Award has been won by Oliver Maddocks. The purpose of this award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory - clinic) cancer research.
SPECTRE study - A study looking at Combined SuPpression of cholEsterol bioavailability and androgen deprivation therapy to treat CastraTion Resistant prostatE cancer
Thu, 15 Dec 2016 11:44:00 GMT
Fri, 30 Sep 2016 15:49:00 BST
Cancer Research UK has today announced its first cross-company deal as part of its Experimental Cancer Medicine Centre (ECMC) Combinations Alliance. MSD, Verastem and Cancer Research UK will trial a new combination of immunotherapy drugs in mesothelioma, non small cell lung and pancreatic cancers. The trial will run through the ECMC network at centres in Edinburgh-Dundee, Southampton, Glasgow, Leicester and Belfast.
Thu, 15 Sep 2016 16:29:00 BST
Scientists at the University of Glasgow have made a second significant breakthrough in the treatment of chronic myeloid leukaemia – using precision medicine to kill more than 90% of chronic myeloid leukaemia (CML) stem cells. The results are published today in the high impact journal Cancer Discovery.
Mon, 29 Aug 2016 13:55:00 BST
Cancer Research UK (CRUK) launches a first-of-its-kind pancreatic cancer clinical trial to make cancer cells more responsive to chemotherapy and radiotherapy, with University of Glasgow researcher Professor Jeff Evans as the chief investigator.
Fri, 10 Jun 2016 15:02:00 BST
New research, by the Universities of Glasgow and Manchester, has revealed an ‘Achilles heel’ of Chronic Myeloid Leukaemia (CML) and found drugs to successfully target this weakness and eradicate the disease in mice.
Thu, 02 Jun 2016 11:56:00 BST
Myeloma UK has awarded grant funding to research teams based at Manchester Royal Infirmary and at the National Institute for Health and Care Excellence (NICE) for two new studies in partnership with Myeloma UK.
Thu, 25 Sep 2014 15:42:00 BST
The new MSc in Cancer Sciences was launched on the 17th of September. ICS are pleased to welcome twenty four students from around the world onto our programme, which takes a “bench to bedside” approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists.
Tue, 25 Mar 2014 12:54:00 GMT
A free six week online course is in progress, which focuses on how modern genetics has revolutionised approaches to the detection and treatment of cancer. It will feature a range of guest lecturers from the College of MVLS including active researchers in the Institutes of Cancer Sciences. The course is suitable for anyone with an interest in cancer genomics, including those interested in applying for the MSc in Cancer Sciences.
Tue, 25 Mar 2014 12:24:00 GMT
Masters in Cancer Sciences is taking applications for a 2014 start. This programme takes a “bench to bedside” approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer diagnosis, research and treatment, including the complexities of early and effective diagnosis, identifying cancer- and patient-specific treatment, and overcoming partial response and recurrence after treatment.
Fri, 04 Apr 2014 10:31:00 BST
Unite Against Cancer has generously agreed to fund a £20,000 scholarship for a student of the new MSc Cancer Sciences programme. Unite Against Cancer is a Glasgow-based charity that was set up in 2012 to fund research into new cancer treatments.